Considering the role of ATX in regulating CSCs and mobility, targeting ATX with inhibitors such as GLPG1690 may also prove to be beneficial in targeting metastasis, particularly in patients living with obesity, by preventing adipose tissue cross talk. This evidence concerns the gene ENPP2 and obesity due to melanocortin 4 receptor deficiency.